Home › Funds › Capricorn Fund Managers Ltd › XENE

Capricorn Fund Managers Ltd position in XENE

XENON PHARMACEUTICALS INC · Health Care

Capricorn Fund Managers Ltd reported holding 568,800 shares of XENE (XENON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$21.2M, representing 2.02% of its reported portfolio and ranking #8 among its reported holdings. Capricorn Fund Managers Ltd has disclosed XENE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)568.80K sh
Reported value held$21.15M
Portfolio Weight2.02%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capricorn Fund Managers Ltd's XENE position evolved

Capricorn Fund Managers Ltd first disclosed a stake in XENE in Q2 2026 at 20,900 shares (US$1.3M). The position peaked in Q3 2026 at 568,800 shares, worth US$21.2M. Across 2 filings, Capricorn Fund Managers Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 568,800 shares valued at US$21.2M — an increase of 547,900 shares quarter over quarter.. Notable position changes include a 2622% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 20.90K $1.26M New
Q3 2026 568.80K $21.15M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XENE and 13F data

XENE (XENON PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XENE

All XENE fund holders →

FAQ

How long has Capricorn Fund Managers Ltd held XENE?

Capricorn Fund Managers Ltd has disclosed XENE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Capricorn Fund Managers Ltd's current position in XENE?

As of Q3 2026, Capricorn Fund Managers Ltd holds 568.80K shares of XENE (XENON PHARMACEUTICALS INC), valued at $21.15M, representing 2.02% of its reported portfolio and ranking #8.

Has Capricorn Fund Managers Ltd been buying or selling XENE?

In the latest 13F filing (Q3 2026), Capricorn Fund Managers Ltd increased its position in XENE. The position peaked in Q3 2026 at 568.80K shares.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.